Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 3
Submit an article Journal homepage
1,264
Views
6
CrossRef citations to date
0
Altmetric
Articles

Evaluation of anxiety and depression in patients with morphea taking immunosuppressive drugs during the COVID-19 pandemic

Mohammad Shahidi Dadrasa Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
,
Zohreh Ahmadzadeha Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
,
Shima Younespourb Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran
&
Fahimeh Abdollahimajda Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran;c Clinical Research Development Unit, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IranCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9463-0665
ORCID Icon
Pages 1406-1412 | Received 08 Aug 2020, Accepted 28 Aug 2020, Published online: 30 Sep 2020

References

  • Alipour A, Ghadami A, Alipour Z, et al. Preliminary validation of the Corona Disease Anxiety Scale (CDAS) in the Iranian sample. Quart J Health Psychol. 2020;8:163–175.
  • Szramka-Pawlak B, Dańczak-Pazdrowska A, Rzepa T, et al. Quality of life and optimism in patients with morphea. Appl Res Qual Life. 2014;9:863–870.
  • Klimas NK, Shedd AD, Bernstein IH, et al. Health-related quality of life in morphoea. Br J Dermatol. 2015;172:1329–1337.
  • Das S, Bernstein I, Jacobe H. Correlates of self-reported quality of life in adults and children with morphea. J Am Acad Dermatol. 2014;70:904–910.
  • Shahidi-Dadras M, Abdollahimajd F, Jahangard R, et al. Magnetic resonance imaging evaluation in patients with linear morphea treated with methotrexate and high-dose corticosteroid. Dermatol Res Pract. 2018;2018:8391218.
  • Röcken M, Ghoreschi K. Morphea Lichen, Sclerosus. In: Bolognia JL, Schaffer JV, Cerroni L, editors. Text book of dermatology. China: Elsevier; 2018. p. 707–721.
  • Bali G, Kárpáti S, Sárdy M, et al. Association between quality of life and clinical characteristics in patients with morphea. Qual Life Res. 2018;27:2525–2532.
  • Shahidi Dadras M, Namazi N, Nikvar M, et al. Challenges faced by patients with morphea in the era of SARS-CoV-2. J Dermatolog Treat. 2020;1–2.
  • Clinical guide for the management of Rheumatology patients during the coronavirus pandemic. Version 2; 2020; [cited 8 Apr 2020]. Available from: https://www.england.nhs.uk/coronavirus/wpcontent/uploads/sites/52/2020/03/clinical-guide-rheumatology-patients-v2-08-april-2020.pdf
  • Conforti C, Giuffrida R, Dianzani C, et al. COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action. Dermatol Ther. 2020;e13298.
  • Albuquerque JVD, Andriolo BNG, Vasconcellos MRA, et al. Interventions for morphea. Cochrane Database Syst Rev. 2019;7:CD005027.
  • Kroft E, de Jong E, Evers A. Psychological distress in patients with morphea and eosinophilic fasciitis. Arch Dermatol. 2009;145:1017–1022.
  • Kaviani H, Seyfourian H, Sharifi V, et al. Reliability and validity of Anxiety and Depression Hospital Scales (HADS): Iranian patients with anxiety and depression disorders. Tehran Univ Med J. 2009;67:379–385.
  • Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370.
  • Bocéréan C, Dupret E. A validation study of the Hospital Anxiety and Depression Scale (HADS) in a large sample of French employees. BMC Psychiatry. 2014;14:354.
  • Salari M, Zali A, Ashrafi F, et al. Incidence of anxiety in Parkinson's disease during the coronavirus disease (COVID-19) pandemic. Mov Disord. 2020;35:1095–1096.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.